CP-31398, a
styrylquinazoline, emerges from a screen for therapeutic agents that restore the wild-type
DNA-binding conformation of mutant p53 to suppress
tumors in vivo, but its effects on
cervical cancer (CC) remain unknown. Hence, this study aimed to explore the effects
CP-31398 has on the CC cells and to investigate whether it is associated with paired box 2 (PAX2) expression. CC cells were treated with different concentrations of
CP-31398 (1, 2, 4, 6, 8, and 10 μg/ml) to determine the optimum concentration using fluorometric microculture cytotoxicity assay. After constructing the sh-PAX2 vector, CC cells were transfected with sh-PAX2 or treated with
CP-31398. The effects of
CP-31398 or PAX2 silencing on CC cell proliferation, apoptosis, invasion, and migration were evaluated. Epithelial mesenchymal transition (EMT)-related genes such as
E-cadherin,
vimentin,
N-cadherin, snail, and twist in CC cells were detected.
Tumor formation experiment in nude mice was performed to observe
tumor growth. The optimum concentration of
CP-31398 was 2 μg/ml. PAX2 was overexpressed in CC cells. CC cells treated with
CP-31398 or treated with sh-PAX2 inhibited proliferation, invasion, and migration but promoted apoptosis with decreased PAX2 expression. The EMT process in CC cells was also reversed
after treatment with
CP-31398 or sh-PAX2. Moreover, the
tumor formation experiment in nude mice revealed the inhibitory activity of
CP-31398 in CC
tumor in nude mice by suppressing PAX2. Our results provide evidence that
CP-31398 could inhibit EMT and promote apoptosis of CC cells to curb CC
tumor growth by downregulating PAX2.